Trials / Recruiting
RecruitingNCT06666790
DermaSensor Postmarket Surveillance Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 396 (estimated)
- Sponsor
- DermaSensor, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the sensitivity of the DermaSensor device and Investigators when used on skin lesions concerning for melanoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Scan with elastic scattering spectroscopy device to assess risk of malignancy | Elastic scattering spectroscopy device uses a spectrum of light reflectance to compare suspicious lesion signature to that of previously scanned lesions with known benign or malignant pathology |
Timeline
- Start date
- 2024-10-08
- Primary completion
- 2027-04-11
- Completion
- 2027-09-10
- First posted
- 2024-10-31
- Last updated
- 2024-10-31
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06666790. Inclusion in this directory is not an endorsement.